Drug-associated pancreatitis: Facts and fiction

Pancreas

Volumn 13, Issue 1, 1996, Pages 100-109

  Rünzi, Michael ^a   Layer, Peter ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acute pancreatitis; Chronic pancreatitis; Drug associated pancreatitis; Drug induced pancreatitis; Review

Indexed keywords

ASPARAGINASE; AZATHIOPRINE; CALCIUM; CYCLOSPORIN A; DIDANOSINE; DIURETIC AGENT; ESTROGEN; PENTAMIDINE; SALICYLIC ACID; TACROLIMUS; TETRACYCLINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HUMAN; PANCREATITIS; PRIORITY JOURNAL;

EID: 0029979068     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199607000-00014     Document Type: Article

References (176)

1. Brockner J, Boisen E. Fatal multisystem toxicity after cotrimoxazole. Lancet 1978;1:831.
2. Barret PVD, Thier SO. Meningitis and acute pancreatitis associated with sulfamethizole. N Engl J Med 1963;268: 36-7.
3. Antonow DR. Acute pancreatitis associated with trimethoprim-sulfamethoxazole. Ann Intern Med 1986;104:363-5.
4. Brazer SR, Medoff JR. Sulfonamide-induced pancreatitis. Pancreas 1988;5:583-6.
5. Elmore MF, Rogge JD. Tetracycline-induced pancreatitis. Gastroenterology 1981;81:1134-6.
6. Torosis J, Vender R. Tetracycline-induced pancreatitis. J Clin Gastroenterol 1987;9:580-1.
7. Schultz JC, Adamson JS, Workman WW, Norman TD. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963;269:999-1004.
8. Kunelis CT, Peters JL, Edmondson HA. Fatty liver of pregnancy and its relationship to tetracycline therapy. Am J Med 1965;38:359-77.
9. Whalley PJ, Adams RH, Combes B. Tetracycline toxicity in pregnancy. JAMA 1964;189:357-62.
10. Tucker PC, Webster PD. Effects of tetracycline on pancreatic protein synthesis and secretion. Clin Res 1972;20:76.
11. Halskell CM, Canellos GP, Leventhal BG, et al. L-Asparaginase - therapeutic and toxic effects in patients with neoplastic disease. N Engl J Med 1969;281:1028-34.
12. Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli L-asparaginase in man. Cancer 1970;25:253-78.
13. Zubrod CG. The clinical toxicities of L-asparaginase. Pediatrics 1970;45:555-8.
14. Whitecar JP, Bodey GP, Harris JE, Freireich EJ. Current concepts. L-Asparaginase. N Engl J Med 1970;282:732-4.
15. Loeb E, Hill JM, Hill NO, et al. Treatment of acute leukemia with L-asparaginase. Recent results. Cancer Res 1970; 33:204-18.
16. Land VJ, Sutow WW, Fernbach DJ, Lane DM, Williams TE Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972;30:339-47.
17. Jaffe N, Traggis D, Das L, et al. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia. Pediatrics 1972;49:590-5.
18. Weetman RM, Baehner RL. Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974;34:780-5.
19. Samuels BI, Culbert SJ, Okamura J, Sullivan MP. Early detection of chemotherapy-related pancreatic enlargement in children using abdominal sonography. A preliminary report. Cancer 1976;38:1515-23.
20. Nguyen DL, Wilson DA, Engelmann ED, Sexauer CL, Nitschke R. Serial sonograms to detect pancreatitis in children receiving L-asparaginase. South Med J 1987;80: 1133-6.
21. McLean R, Martin S, Lam-Po-Tang PRL. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982;2: 1401-2.
22. Shaw MT, Barnes CC, Madden FJF, Bagshawe KD. L-Asparaginase and pancreatitis. Lancet 1970;2:721.
23. Greenstein R, Nogeire C, Ohnuma T, Greenstein A. Management of asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst. Cancer 1979;43:718-22.
24. Puckett JB, Butler WM, McFarland JA. Pancreatitis and cancer chemotherapy. Ann Intern Med 1982;97:453.
25. Newman CE, Ellis DJ. Pancreatitis during combination chemotherapy. Clin Oncol 1979;5:83-4.
26. Nevalainen TJ. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells. Virchows Arch B Zellpathol 1975;18:119-27.
27. Socinski MA, Garwick MB. Acute pancreatitis associated with chemotherapy for germ cell tumors in two patients. Ann Intern Med 1988;108:567-8.
28. Sturdevant RAL, Singleton JW, Deren JJ, Law DH, McCleery JL. Azathioprine-related pancreatitis in patients with Crohn's disease. Gastroenterology 1979;77:883-6.
29. Nogueira JR, Freedman MA. Acute pancreatitis as a complication of imuran therapy in regional enteritis. Gastroenterology 1972;62:1040-1.
30. Major GAC, Moore PG. Profound circulatory collapse due to azathioprine. J R Soc Med 1985;78:1052-3.
31. Kwanishi H, Rudolph E, Bull FE. Azathioprine-induced acute pancreatitis. N Engl J Med 1973;289:357.
32. Isenberg JN. Pancreatitis, amylase clearance, and azathioprine. J Pediatr 1978;93:1043-4.
33. Guillaume P, Grandjean E, Malè PJ. Azathioprine-associated acute pancreatitis in the course of chronic active hepatitis. Dig Dis Sci 1984;29:78-80.
34. Paloyan D, Levin B, Simonowitz D. Azathioprine-associated acute pancreatitis. Am J Dig Dis 1977;22:839-40.
35. Bank L, Wright JP. 6-Mercaptopurine-related pancreatitis in 2 patients with inflammatory bowel disease. Dig Dis Sci 1984;29:357-9.
36. Haber CJ, Meltzer SJ, Present DH, Korelitz BI. Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 1986;91:982-6.
37. Wolley PV III Hepatic and pancreatic damage produced by cytotoxic drugs. Cancer Treat Rev 1983;10:117-37.
38. Broe PJ, Cameron JL. Azathioprine and acute pancreatitis. Studies with an isolated perfused canine pancreas. J Surg Res 1983;34:159-63.
39. Dreiling DA, Nacchiero M. The effect of imuran on pancreatic secretion. Am J Gastroenterol 1978;69:491-3.
40. Kernstein MD, Grabman JP. Azathioprine as a treatment modality in acute hemorrhagic pancreatitis. Surg Forum 1978;29:453.
41. Miller TL, Winter HS, Luginbuhl LM, Orav EJ, McIntosh K. Pancreatitis in pediatric human immunodeficiency virus infection. J Pediatr 1992;120:223-7.
42. Pauwels A, Eliaszewicz M, Larrey D, et al. Pentamidine-induced acute pancreatitis in a patient with AIDS. J Clin Gastroenterol 1990;12:457-9.
43. Herer B, Chient T, Labrune S, Collignon MA, Chretien J, Huchon G. Pancreatitis associated with pentamidine by aerosol. Br Med J 1989;298:605.
44. Kumar S, Schnadig VJ, MacGregor MG. Fatal acute pancreatitis associated with pentamidine therapy. Am J Gastroenterol 1989;84:451-3.
45. Salmeron S, Petitpretz P, Katlama C, et al. Pentamidine and pancreatitis. Ann Intern Med 1986;105:140-1.
46. Hart CC. Aerosolized pentamidine and pancreatitis. Ann Intern Med 1989;111:691.
47. Schwartz MS, Cappel MS. Pentamidine-associated pancreatitis. Dig Dis Sci 1989;34:1617-20.
48. Zuger A, Wolf BZ, El-Sadr W, Simberkoff MS, Rahal JJ. Pentamidine-associated fatal acute pancreatitis. JAMA 1986;256:2383-5.
49. Murphey SA, Josephs AS. Acute pancreatitis associated with pentamidine therapy. Arch Intern Med 1981;141:56-8.
50. Clas D, Falutz J, Rosenberg L. Acute pancreatitis associated with HIV infection. Can Med Assoc J 1989;140:823.
51. Brivet F, Coffin B, Bedosa P, et al. Pancreatic lesions in AIDS. Lancet 1987;2:570-1.
52. Buchard PH, Sai P, Reach G. Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 1982;31:40-5.
53. Boillot D, Veld P, Sai P. Functional and morphological modifications induced in rat islets by pentamidine and other diamidines in vitro. Diabetologica 1985;28:359-64.
54. Pike IM, Nicaise C. The didanosine expanded excess program: safety analysis. Clin Infect Dis 1993;16 (Suppl 1): S63-8.
55. Butler KM, Venzon D, Henry N, et al. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993;91:747-51.
56. Seidlin M, Lambert JS, Dolin R, Valentine FT. Pancreatitis and pancreatic dysfunction in patients taking dideoxyinosine. AIDS 1992;6:831-5.
57. Moyle GJ, Nelson MR, Hawkins D, Gazzard BG. The use and toxicity of didanosine (ddl) in HIV antibody-positive individuals intolerant to zidovudine (AZT). Q J Med 1993; 86:155-63.
58. Layer P, Hotz J, Schmitz-Moormann HP, Goebell H. Effects of experimental chronic hypercalcemia on feline exocrine pancreatic secretion. Gastroenterology 1982;82:309-16.
59. Layer P, Hotz J, Cherian L, Goebell H. In vitro stimulation of pancreatic enzyme discharge by elevated extracellular calcium concentrations. Gut 1987;28:1215-20.
60. Layer P, Hotz J, Eysselein VE, et al. Effects of acute hypercalcemia on exocrine pancreatic secretion in the cat. Gastroenterology 1985;88:1168-74.
61. Frick TW, Fryd DS, Sutherland DER, Goodale RL, Simmons RL, Najarian JS. Hypercalcemia associated with pancreatitis and hyperamylasemia in renal transplant recipients. Data from the Minnesota randomized trial of cyclosporine versus antilymphoblast azathioprine. Am J Surg 1987;154:487-9.
62. Fernandez-del Castillo C, Harringer W, Warshaw AL, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991;325:382-7.
63. Leeson PM, Fourman P. Acute pancreatitis from vitamin-D poisoning in a patient with parathyroid deficiency. Lancet 1966;1:1185-86.
64. Meltzer LE, Palmon FP, Paik YK, Custer RP. Acute pancreatitis secondary to hypercalcemia of multiple myeloma. Ann Intern Med 1962;57:1008-12.
65. DeWaele B, Smith J, Willems G. Recurrent pancreatitis secondary to hypercalcemia following vitamin D poisoning. Pancreas 1989;4:378-80.
66. Izsak EM, Shilke M, Roulet M, Jeejeebhoy KN. Pancreatitis in association with hypercalcemia in patients receiving total parenteral nutrition. Gastroenterology 1980;79: 555-8.
67. Bourke JB, McIllmurray MB, Mead GM, Langman MJS. Drug-associated primary acute pancreatitis. Lancet 1978;1: 706-8.
68. Moir DC. Drug-associated acute pancreatitis. Lancet 1978; 2:369-70.
69. Eckhauser ML, Dokler MA, Imbembo AL. Diuretic-associated pancreatitis: a collective review and illustrative cases. Am J Gastroenterol 1987;82:865-70.
70. Pickleman J, Straus FH, Paloyan E. Pancreatitis associated with thiazide administration. Arch Surg 1979;114:1013-16.
71. Paloyan E, Forland M, Pickleman JR. Hyperparathyreoidism coexisting with hypertension and prolonged thiazide administration. JAMA 1969;210:1243-5.
72. Thomas FB, Sinar D, Caldwell JH, Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology 1977;73:221-5.
73. Holland SD, Williamson HE. Acute effects of high ceiling diuretics on pancreatic blood flow and function. J Pharmacol Exp Ther 1984;229:440-6.
74. Faintuch J, Mott CB, Machado MCC. Pancreatitis and pancreatic necrosis during sulfasalazine therapy. Int Surg 1985; 70:271-2.
75. Block MB, Genant HK, Kirsner JB. Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med 1970;282:380-2.
76. Suryapranta H, de Vries H. Pancreatitis associated with sulfasalazine. Br Med J 1986;292:732.
77. Chiba M, Horie Y, Ishgida H, Arakawa H, Masamune O. A case of salicylazosulfapyridine induced acute pancreatitis with positive lymphocyte stimulation test. Gastroenterol Jpn 1987;22:228-33.
78. Poldermans D, Van Blankenstein M. Pancreatitis induced by disodium azodisalicylate. Am J Gastroenterol 1988;83: 578-30.
79. Eckardt VF, Kanzler G, Rieder H, Ewe K. 5-Aminosalicylsäure-assoziierte Pankreatitis (English abstract). Dtsch Med Wschr 1991;116:540-2.
80. Fiorentini MT, Fracchia M, Galatola G, Barlotta A, De La Pierre M. Acute pancreatitis during oral 5-aminosalicylic acid therapy. Dig Dis Sci 1990;35:1180-2.
81. Deprez P, Deschamps CH, Fiasse R. Pancreatitis induced by 5-aminosalicylic acid. Lancet 1989;2:445-6.
82. Sachedina B, Saibil F, Cohen LB, Whittey J. Acute pancreatitis due to 5-aminosalicylate. Ann Intern Med 1989; 110:490-2.
83. VanArsdel PP Jr. Adverse drug reactions. In: Middleton E Jr, Reed DE, Ellis FF, eds. Allergy: principles and practice. St. Louis, MO: Mosby, 1983:1389-1414.
84. Isaacs KL, Murphy D. Pancreatitis after rectal administration of 5-aminosalicylic acid. J Clin Gastroenterol 1990;12: 198-9.
85. Mosley JG, Fox JN, Reber HA. Aspirin secretion by the pancreas: effect on the pancreatic duct mucosal barrier. Surgery 1979;86:17-22.
86. Wedgwood KR, Adler G, Kern H, Reber HA. Effect of oral agents on pancreatic duct permeability. A model of acute alcoholic pancreatitis. Dig Dis Sci 1986;31:1081-8.
87. Bank S, Marks IN. Hyperlipemic pancreatitis and the pill. Postgrad Med J 1970;46:576-88.
88. Glueck CJ, Scheel D, Fishback J, Steiner P. Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism 1972;21: 657-66.
89. Parker WA. Estrogen-induced pancreatitis (clinical conference). Clin Pharm 1983;2:75-9.
90. Foster ME, Powell DEB. Pancreatitis, multiple infarcts and oral contraception. Postgrad Med J 1975;51:667-9.
91. Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med 1973;289:552-5.
92. Mungall IPF, Hague RV. Pancreatitis and the pill. Postgrad Med J 1975;51:855-7.
93. Sandberg AA, Kirdani RY, Varakarkis MJ, Murphy GP. Estrogen receptor protein of pancreas. Steroids 1973;22: 259-71.
94. Goldman JA, Ovadia JL. The effect of estrogen in intravenous glucose tolerance in women. Am J Obstet Gynecol 1969;103:172-8.
95. Wyllie E, Wyllie R, Cruse RP, Erenberg G, Rothner D. Pancreatitis associated with valproic acid therapy. Am J Dis Child 1984;138:912-4.
96. Coulter DL, Allen R. Pancreatitis associated with valproic acid therapy for epilepsy. Ann Neurol 1080;7:92.
97. Camfield PR, Bagnell P, Camfield CS, Tibbles JAR. Pancreatitis due to valproic acid. Lancet 1979;1:1198.
98. Batalden PB, Van Dyne BJ, Cloyd JP. Pancreatitis associated with valproic acid therapy. Pediatrics 1979;64:520-2.
99. Sasaki M, Tonoda S, Aoki Y, Katsumi M. Pancreatitis due to valproic acid. Lancet 1980;1:1196.
100. Parker PH, Helinek GL, Ghishan FK, Greene HL. Recurrent pancreatitis induced by valproic acid. Gastroenterology 1981;80:826-8.
101. Walker RM, Smith GS, Barsoum NJ, Macallum GE. Pre-clinical toxicology of the anticonvulsant calcium valproate. Toxicology 1990;63:137-55.
102. Kaplan MH, Dreiling DA. Steroid revised. II. Was cortisone responsible for the pancreatitis? Am J Gastroenterol 1977;67:141-7.
103. Steinberg WM, Lewis JH. Steroid-induced pancreatitis: does it really exist? Gastroenterology 1981;81:799-808.
104. Howard JM. Pancreatitis: Multiple diseases with multiple causes and varying natural histories. In: Howard JM, Jordan GL, Reber HA, eds. Surgical diseases of the pancreas. Philadelphia: Lea & Febiger, 1987:204-7.
105. Bencosme SA, Lazarus SS. The pancreas of cortisone treated rabbits. Arch Pathol 1956;62:285-95.
106. Stumpf HH, Wiens SL, Somoza C. Pancreatic lesions and peripancreatic fat necrosis in cortisone-treated rabbits. Lab Invest 1956;5:224-35.
107. Lazarus SS, Bencosme SA. Alterations of pancreas during cortisone diabetes in rabbits. Proc Soc Exp Biol Med 1955; 89:114-8.
108. Zeitz M, Emde C, Gartemann H, Stelzer M, Riecken EO. Ultrastructural and biochemical changes of the rat exocrine pancreas under the influence of high-dose cortisone. Gastroenterology 1985;88:A1642.
109. Ruud TE, Aasen AO, Roise O, Lium B, Pillgram-Larsen J, Stadaas JO. Effects on peritoneal proteolysis and hemodynamics by high doses of methyl-prednisolone in experimental acute pancreatitis. Scand J Gastroenterol 1986;21 (Suppl 126):25-31.
110. Kimura T, Zuidema GD, Cameron JL. Acute pancreatitis: experimental evaluation of steroid, albumin and trasylol therapy. Am J Surg 1980;140:403-8.
111. Sudley JGN, Schenk WG. Pathophysiology of acute pancreatitis. Evaluation of the effect and mode of action of steroids in experimental pancreatitis in dogs. Am J Surg 1982;143:761-4.
112. Hahn HJ, Laube F, Lucke S, Kloting I, Kohnert KD, Warzock R. Toxic effects of cyclosporin A on the endocrine pancreas of Wistar rats. Transplantation 1986;41:44-7.
113. Yale JF, Roy RD, Grose M, Seemayer TA, Murphy GR, Marlis EB. Effects of cyclosporin A on glucose tolerance in the rat. Diabetes 1985;34:1309-13.
114. Helmchen U, Schmidt EW, Siegel EG, Creutzfeldt W. Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats. Diabetologia 1984;27:416-8.
115. Yoshimura N, Nakai I, Ohmori Y, et al. Effect of cyclosporine on endocrine and exocrine pancreas in kidney transplant recipients. Am J Kidney Dis 1988;12:11-7.
116. Lober MI, Buren CTV, Flechner SM, Williams C, Kahan BD. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation 1987;43:35-40.
117. Watson CJE, Jamieson NV, Johnston PS, et al. Early abdominal complications following heart and heart-lung transplantation. Br J Surg 1991;78:699-704.
118. Ito T, Kimura T, Toshinari K, et al. Acute pancreatitis induced by cyclosporin A under stimulation of pancreas by caerulein. Pancreas 1993;8:693-9.
119. Kenmochi T, Asano T, Shimada H, Ochiai T, Isono K. Clinical and experimental studies of acute pancreatitis after renal transplantation. Transplant Proc 1992;24:1578-80.
120. Uemoto S, Tanaka K, Honda K, et al. Experience with FK506 in living-related liver transplantation. Transplantation 1993;55:288-92.
121. McDiarmid SV, Klintmalm G, Busuttil RW. FK506 rescue therapy in liver transplantation: outcome and complications. Transplant Proc 1991;23:2996-9.
122. Müller MK, Wojcik M, Coone H, Philipp T, Singer MV. Inhibition of insulin release by FK 506 and its prevention by rioprosil, a stable prostaglandin E1 analogue. Transplant Proc 1991;23:2812-3.
123. Sastri SV, Diaz-Arias AA, Marshall JB. Can pancreatitis be associated with amiodarone hepatotoxicity? J Clin Gastroenterol 1990;12:70-7.
124. Branch A. Pancreatic necrosis in ethyl alcohol, methyl alcohol and arsenic poisoning. Can Med Assoc J 1944;51: 428-30.
125. Durrington PN, Cairns SA. Acute pancreatitis: a complication of beta-blockade. Br Med J 1982;284:1016.
126. Soman M, Swenson C. A possible cause of carbamazepine-induced pancreatitis. Drug Intell Clin Pharm 1985;19: 925-6.
127. Speckmann K. Über Pankreasschädigungen durch Tetrachlorkohlenstoff. Ärztl Wochenschr 1953;8:1051-102.
128. Moon HD. The pathology of fatal carbon-tetrachloride poisoning with special reference of the histogenesis of the hepatic and renal lesions. Am J Pathol 1950;26:1041-57.
129. Keane FBV, Fennell JS, Tomkin GH. Acute pancreatitis, acute gastric dilatation and duodenal ileus following refeeding in anorexia nervosa. Ir J Med Sci 1978;147:191-2.
130. Casdorph HR. The efficacy and safety of cholestyramine therapy in hyperlipidemic patients. Ann Intern Med 1971; 74:818.
131. Committee of Principal Investigators. A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978;40:1069-118.
132. Freemann JS, Panebianco PS. Colchicine overdosage: report of a case. JAMA 1982;82:252-4.
133. Naidus RM, Rodvien R, Mielke H. Colchicine toxicity. Arch Intern Med 1977;137:394-6.
134. Chin WS, Ng R. Acute fulminant pancreatitis following ventriculography. Cardiovasc Intervent Radiol 1981;4: 108-9.
135. Cunliffe WJ, Cobden I, Lavelle MI, Lendrum R, Tait NP, Venables CW. A randomized, prospective study comparing two contrast media in ERCP. Endoscopy 1987;19:201-2.
136. Lotveit T, Larsen S, Gronseth K, Osnes M. The probability of pancreatitis after pancreatic parenchymatography with a non-ionic contrast medium. Scand J Gastroenterol 1987;22: 111-6.
137. Chevalier X, Awada H, Baetz A, Amor B. Danazol induced pancreatitis and hepatitis. Clin Rheumatol 1990;9:239-41.
138. McCormick PA, O'Donoghue D, Brennan N. Diphenoxylate and pancreatitis. Lancet 1985;1:752.
139. Roush MK, McNutt RA, Gray TF. The adverse effect dilemma: quest for accessible information. Ann Intern Med 1991;114:298-9.
140. Tilkemeier P, Thompson PD. Acute pancreatitis possibly related to enalapril. N Engl J Med 1988;318:1275-6.
141. Deviere J, Reuse C, Askenasi R. Ischemic pancreatitis and hepatitis secondary to ergotamine poisoning. J Clin Gastroenterol 1987;9:350-2.
142. Tschantz P, Favre H. Pancréatitie nécrosante par intoxication à l'acide formique et brulure à l'acide fluorhydrique. Schweiz Rundsch Med Prax 1975;64:487-90.
143. Eisemann AD, Becker NJ, Miner PB, Fleming J. Pancreatitis and gold treatment of rheumatoid arthritis. Ann Intern Med 1989;111:860-1.
144. Schrogi JJ, Holt P, Hartley RC, Bartholomew LG. "Histamine-induced" pancreatitis. Gastroenterology 1965;49: 672-5.
145. Calmus Y, Biour M, Bodin F, Cheymol G, Garnis F. Hépatites et pancréatite à l'indalpine. Gastroenterol Clin Biol 1985;9:266-8.
146. Noseworthy J, Colodny AH, Eraklis AJ. Pancreatitis and intravenous fat: an association in patients with inflammatory bowel disease. J Pediatr Surg 1983;18:269-72.
147. Buckspan R, Woltering E, Waterhouse G. Pancreatitis induced by intravenous infusion of a fat emulsion in an alcoholic patient. South Med J 1984;77:251-2.
148. Lashner BA, Kirsner JB, Hanauer SB. Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease. Gastroenterology 1986;90:1039-41.
149. Flynn WJ, Freeman PG, Wickboldt LG. Pancreatitis associated with Isotretinoin-induced hypertriglyceridemia. Ann Intern Med 1987;107:63.
150. Middleton SJ, Jacyna M, McClaren D, Robinson R, Thomas HC. Hemorrhagic pancreatitis - a cause of death in severe potassium permanganate poisoning. Postgrad Med J 1990;66:657-8.
151. Pluhar W. Ein Fall möglicher Lovastatin-induzierter Pankreatitis bei gleichzeitigem Gilbert-Syndrom. Wien Klin Wochenschr 1989;101:551-4.
152. Bourry J, Sainty JM, Roux JJ, Ressiot G. Pancréatitis aigues au cours d'intoxications au méprobamate. Nouv Press Méd 1976;5:1918.
153. Meyers DH. Pancreatitis, panniculitis and methandienone. Aust NZ J Med 1982;12:302-5.
154. Sanford EW, Mitas JA, Swerdlin AHR. Pancreatitis due to methyldopa: case report. Miliit Med 1980;145:399-400.
155. Rominger JM, Gutierrez JG, Curtis D, Chey WY. Methyldopa-induced pancreatitis. Am J Dig Dis 1978;23:756-8.
156. Van der Heide H, Ten Haaft MA, Stricker BMC. Pancreatitis caused by methyldopa. Br Med J 1981;282:1930-1.
157. Stecyk O, Loludice TA, Demeter S, Jacobs J. Multiple organ failure resulting from intravenous abuse of methylphenidate hydrochloride. Ann Emerg Med 1985;14:597-9.
158. Bennett IL, Nation TC, Olley JF. Pancreatitis in methyl alcoholic poisoning. J Lab Clin Med 1952;40:405-9.
159. Bennett IL, Freeman HC, Mitchell GL, Cooper MN. Acute methyl alcoholic poisoning: a review based on experiences in an outbreak of 323 cases. Medicine 1953;32:431-63.
160. Donovan KL, White AD, Cooke DA, Fisher DJ. Pancreatitis and palidromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant patient. J Infect 1990;21:107-10.
161. Du Ville L, Debeuckelaere S, Reynaert H, Devis G. Pancreatitis associated with naproxen. Am J Gastroenterol 1993;88:464.
162. Nelis GF. Nitrofurantoin-induced pancreatitis: report of a case. Gastroenterology 1983;84:1032-4.
163. Braganza JM, Jolley JE, Lee WR. Occupational chemical and pancreatitis: a link? Int J Pancreatol 1986;1:9-19.
164. Lambrianides AL, Rosin RD. Acute pancreatitis complicating excessive intake of phenolphthalein. Postgrad Med J 1984;60:491-2.
165. Falco JM, Thomas FB. Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med 1975; 83:832-33.
166. Jeffries JJ, Masson J. Pancreatitis following overdose with amoxapine and proxyclidine. Can J Psychiatr 1985;30: 546-7.
167. Larsen RR, Sawyer RB, Sawyer KC, McCurdy RE. Hemorrhagic pancreatitis complicating anticoagulant therapy. NY State J Med 1962;XX:2397-9.
168. Foitzik T, Bassi DG, Schmidt J, et al. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat. Gastroenterology 1994;106:207-14.
169. Rünzi M, Raptopoulos V, Saluja A, et al. Evaluation of necrotizing pancreatitis in the opossum by dynamic contrast-enhanced computerized tomography: correlation between radiographic and morphologic changes. Am Coll Surg 1995;180:673-82.
170. Sherman S, Lehman GA. ERCP and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991;6:350-67.
171. Barkin JS, Casai GL, Reiner DK. A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroenterol 1991;86:1437-41.
172. Hangartner PJ, Bühler H, Münch R, Zaruba K, Stamm B, Ammann R. Chronische Pankreatitis als wahrscheinliche Folge eines Analgetikaabusus. Schweiz Med Wschr 1987; 117:638-42.
173. Banerjee AK, Patel KJ, Grainger SL. Drug-induced pancreatitis: a critical review. Med Toxicol Adverse Drug Exp 1989;4:186-98.
174. Steinberg WM. Acute drug and toxin induced pancreatitis. Hosp Practice (Off Ed) 1985:20(5):95-102.
175. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-210.
176. Mofenson HC, Caraccio TR, Nawaz H, Steckler G. Acetaminophen induced pancreatitis. J Toxicol Clin Toxicol 1991;29:223-30.